A comprehensive mechanistic understanding between ANO1 expression and HNSCC tumorigenesis is still lacking, but the frequency of its overexpression in HNSCC [26] suggests that ANO1 might be a potent target for pharmacological intervention. The gene discussed is ANO1; the disease is head and neck squamous cell carcinoma.